Posts
September 05 2012
Crowdfund Capital Advisors has written a whitepaper titled "How Crowdfund Investing Helps Solve Three Pressing Socioeconomic Challenges." EG&S sponsored the whitepaper.
August 20 2012
BioSante Pharmaceuticals, Inc. announced the closing of their Registered Direct offering in the amount of $3,474,999. EG&S acted as counsel to the placement agent.
August 15 2012
Arrowhead Research Corp. announced the closing of their Registered Direct offering in the amount of $6,240,000. EG&S acted as counsel to the placement agent.
August 14 2012
Generex Biotechnology Corporation announced the closing of their Registered Direct offering in the amount of $750,000. EG&S acted as counsel to the Investor.
August 13 2012
Eco Building Products, Inc. announced the closing of their PIPE offering in the amount of $1,080,000. EG&S acted as counsel to the Investor.
August 08 2012
ARCA biopharma, Inc. announced the closing of their Registered Direct offering in the amount of $952,710. EG&S acted as counsel to the placement agent.
August 07 2012
pSivida Corp. announced the closing of their Registered Direct offering in the amount of $5,363,000. EG&S acted as counsel to the placement agent.
August 06 2012
Stevia Corp. announced the closing of their PIPE offering in the amount of $500,000. EG&S acted as counsel to the Investor.